Winning Confectionery
This carefully curated collection features the market leaders in candy, chocolate, and sweet treats. Handpicked by our analysts, these companies deliver the small indulgences consumers consistently buy, even during economic downturns.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
About This Group of Stocks
Our Expert Thinking
We've identified the confectionery giants that dominate the world's sweet cravings. These companies offer defensive growth potential through their established brands and consistent consumer demand for affordable luxuries, regardless of economic conditions.
What You Need to Know
These stocks combine stability with growth opportunities. Many are consumer staples with substantial market share, global distribution networks, and consistent innovation pipelines. Several also offer dividend income, making them potentially attractive for balanced portfolios.
Why These Stocks
Our analysts selected these companies for their brand power, proven track records, and ability to adapt to changing consumer preferences. From chocolate giants to bakery leaders, each has demonstrated expertise in creating products consumers love while expanding into new markets.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+23.77%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 23.77% over the next year.
Stocks Rated Buy by Analysts
9 of 15 assets in this group are rated Buy by professional analysts.
Why You'll Want to Watch These Stocks
Sweet Treats, Sweeter Returns
These companies create the guilty pleasures consumers consistently purchase, offering potential stability when other sectors falter.
Global Growth Appetite
Emerging markets present massive growth opportunities as rising incomes fuel demand for branded sweet treats across Asia, Africa, and Latin America.
Recession-Resistant Rewards
History shows people still buy affordable luxuries during economic downturns, making confectionery stocks potentially resilient when other investments struggle.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.